Previous 10 | Next 10 |
home / stock / tomdf / tomdf news
Company also retains B2i Digital to enhance engagement with the investor community New York, NY, and Tel Aviv, ISRAEL, Sept. 02, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions c...
New York, NY, and Tel Aviv, ISRAEL, Aug. 31, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that it has entered into a lease agreement in Cleburn, TX area for a 1...
New York, NY, and Tel Aviv, ISRAEL - ( NewMediaWire ) - August 29, 2022 - Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its Atlanta-area CLIA/CAP-certified clinical laboratory, Provista Diagnostics...
Patient denied testing for weeks due to risk of physician infection & non-MSM status Amerimmune Long COVID Panel and Provista research-use-only MonkeyPox assays to assess effect of TPoxx intervention on Long COVID and MonkeyPox biomarkers Risk of MonkeyPox infection ...
New York, NY, and Tel Aviv, ISRAEL, Aug. 23, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its Atlanta-area CLIA/CAP-certified clinical laboratory Provista ...
Todos Medical press release ( OTCQB:TOMDF ): Q2 GAAP EPS of -$0.01. Revenue of $2.18M (+26.0% Y/Y). For further details see: Todos Medical GAAP EPS of -$0.01, revenue of $2.18M
Preparations for Tollovir™ Phase 2 Trial Extension to Support EUA Filing Now Complete Preparations for Tollovid™ Phase 2 Trial in Long COVID Now Complete Launch of New Suite of PCR Tests at Provista Underway, Including MonkeyPox Saliva Testing NEW Y...
Todos Medical ( OTCQB:TOMDF ) said its laboratory Provista Diagnostics completed CLIA validation and commercially launched lesion and saliva-based monkeypox PCR testing in the U.S. Provista will collect saliva samples matched with lesion swabs from confirmed Monk...
Provista begins validation preparations for blood-based IgM/IgG MonkeyPox LDT Company to release its Q2/2022 10Q quarterly report at 4:05 pm ET this afternoon Company to host business update conference call on Tuesday, August 23 rd at 8:30 am ET Tel Aviv - ( NewMediaWir...
Todos Medical ( OTCQB:TOMDF ) said its majority-owned joint venture 3CL Pharma reported results from the first 100-participant study from an Institutional Review Board-waived market research study of Tollovid in long COVID patients. The company said participants ...
News, Short Squeeze, Breakout and More Instantly...
Todos Medical Ltd Company Name:
TOMDF Stock Symbol:
OTCMKTS Market:
Signature Bank (SBNY) is expected to report for Q3 2023 BHP Group Ltd. (BHP) is expected to report for Q1 2024 Sorrento Therapeutics Inc. (SRNEQ) is expected to report $-0.15 for Q3 2023 Baran Group Ltd. (BRANF) is expected to report for quarter end 2023-09-30 World Copper (WCUFF)...
NEW YORK, NY, ALPHARETTA, GA and TEL AVIV, Israel, Dec. 22, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF) , an innovative healthcare solutions company, today announced that a trustee was appointed (the “Trustee”) with respect to an insol...
GLG Life Tech Corporation (GLGLF) is expected to report for Q1 2024 Accenture plc Class A (Ireland) (ACN) is expected to report $3.14 for Q1 2024 Greenlane Holdings Inc. (GNLN) is expected to report $-2.7 for Q3 2023 iMedia Brands Inc. (IMBIQ) is expected to report for quarter end 202...